There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
2748.54 Cr.Face value
2.00Book value
22.75Div. yield
0.40%P/E ratio
28.97P/B ratio
2.21Debt/Eq.
0.07Market Cap
2748.54 Cr.Face value
2.00Book value
22.75Div. yield
0.40%P/E ratio
28.97P/B ratio
2.21Debt/Eq.
0.07
| Mar 26 | Dec 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 35.65% | 35.65% | 0.00% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs Home Diagnostics Formulations and OTC products. The plant at Masulkhana is for manufacture of Loratadine an anti-allergy drug - internationally known as Claritin. Di 
Morepen manufactures APIs, branded and generic formulations, OTC products and Home Health devices, serving both domestic and global markets. Its manufacturing is based in Himachal Pradesh.
The company is listed on BSE and NSE. Its plants are in Baddi, Parwanoo and Masulkhana in Himachal Pradesh.
The consolidated group comprises seven subsidiaries. On a consolidated basis, APIs contribute 53.5% of revenue, followed by Diagnostics at 27.5%, Formulations at 10% and OTC at 9%.
